Marion Gruber is the Signatory Authority listed on the Emergency Use Authorization. Marion Gruber, director of the FDA’s Office of Vaccines Research & Review, and deputy director Phil Krause will exit the agency in October and November, respectively, according to a letter shared with CNBC by FDA spokeswoman Stephanie Caccomo. A former senior FDA leader…
Tag: Phil Krause
Uncategorized
FDA advisory committee voted 16 to 2 against boosters
According to Dr. Steve Kirsch, the “elephant in the room” is: People killed > People saved In other words, you are more likely to die from the vaccine than from COVID-19. See the outtake video and Dr. Steve Kirsch’s slides from the meeting. The FDA held a Vaccine Advisory Committee meeting on September 17, 2021…